« Previous Next » Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 4 , Pages 267-270 , December 2008

Flourescence cystoscopy—How to do it

References

Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. Journal of Urology. 2002;168:67–71
Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. Journal of Photochemistry and Photobiology B. 1992;14:275–292
Sima AA, Kennedy JC, Blakeslee D, Robertson DM. Experimental porphyric neuropathy: a preliminary report. Canadian Journal of Neurological Science. 1981;8:105–113
Pottier RH, Chow YF, LaPlante JP, Truscott TG, Kennedy JC, Beiner LA. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Journal of Photochemistry and Photobiology B. 1986;44:679–687
Kriegmair M, Baumgartner R, Knuechel R, et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology. 1994;44:836–841
Steinbach P, Kriegmair M, Baumgartner R, Hofstadter F, Knuchel R. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. Urology. 1994;44:676–681
Zaak D, Kriegmair M, Stepp H, et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology. 2001;57:690–694
Stenzl A, Hoeltl L, Bartsch G. Fluorescence-assisted transurethral resection of bladder tumors: is it cost-effective?. European Urology. 2001;39(Suppl. 5):1–216
- MEDLINE
- CrossRef
Filbeck T, Pichlmeier U, Knuchel R, Wieland WF, Rößler W. Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid induced fluorescence diagnosis. Results of a 5-year study. Urologe A. 2003;42:1366–1373
- MEDLINE
- CrossRef